Here are five observations:
1. Abbott, Boston Scientific, LiveNova (Cyberonics), Nevro Corp., Autonomic Technologies, Inspire Medical System and NeuroPace are all key market players.
2. The growing geriatric population and rise in prevalence of neurological diseases will spark market growth. Opportunities for new technology development will also boost the market.
3. The costliness of neurological disease treatment and dearth of trained professionals will stunt market growth, however.
4. Europe is the second greatest contributor to the global market, with an anticipated increase in research and development in the field.
5. The Asia-Pacific region will witness market growth because of more government efforts highlighting public health.
More aritcles on devices:
K2M exceeds 100th-product milestone with OZARK Cervical Plate Systems clearance: 4 highlights
Medtronic whistleblower lawsuit to play out in court: 3 insights
Stryker, Medtronic, K2M & more: 11 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.